Active Ingredient
salicylic acid 15%
Irlvixro Wart Remover For Common Plantar Warts Liquid
FDA Label NDC 87273-002
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Shenzhen Xituo Electronics Co., Ltd for the product Irlvixro Wart Remover For Common Plantar Warts (NDC 87273-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use, warnings, do not use, when using, stop use, ask doctor, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Purpose
Wart remover
Use
for the removal ofcommon and plantar warts
Warnings
for external use only
Do Not Use
on moles, birthmarks, or warts with hair growing from them
on irritated skin or on any area that is infected or reddened
if you have diabetes or poor blood circulation
When Using
avoid contact with eyes
if product gets into eyes, flush with water for 15 minutes
Stop Use
discomfort persists
excessive irritation occurs
Ask Doctor
discomfort persists
excessive irritation occurs
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
wash affected area
may soak wart in warm water for 5 minutes
dry area thoroughly
using the applicator, apply one drop at a time to sufficiently cover each wart
let dry
repeat this procedure once or twice daily as needed (until wart is removed)
treatment may take up to 12 weeks
Other Information
store at 20–25°C (68–77°F)
keep bottle tightly closed
protect from freezing
avoid excessive heat or flame
Inactive Ingredients
ALCOHOL, PROPYLENE GLYCOL, WATER, PENTYLENE GLYCOL, OLETH-20, PEG-40 HYDROGENATED CASTOR OIL
CYMBOPOGON CITRATUS LEAF OIL, POLYETHYLENE GLYCOL 400
Principal Display Panel
1 (Label)
* Please review the disclaimer below.
